Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atraxis-X
- Development stage
- Preclinical
- Lead developer
- Lurex Bio
- Modality
- Drug Delivery Systems, Vaccines & Immunotherapeutics
01
Overview
Atraxis-X is a next-generation immune-engineering platform developed by Lurex Bio Inc., designed to overcome tumor immune evasion in 'cold' solid tumors. As an adaptive fusion vesicle platform, Atraxis-X functions by fusing synthetic immune signals directly onto the membranes of tumor cells, effectively 'tagging' them to be recognized by the patient's own T-cells and natural killer (NK) cells. The platform incorporates advanced logic controls to ensure selective fusion and orientation-controlled display of immune cues, while also allowing for the co-delivery of therapeutic payloads. By transforming immunologically silent tumors into visible targets, Atraxis-X aims to restore the body's natural anti-tumor response without the need for genetic modification or viral vectors. The technology is currently in the preclinical stage, with ongoing development focused on optimizing signal density and orientation for clinical applications.
- Brand names
- Atraxis-X
Beyond the preview
Go deeper on Atraxis-X.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atraxis-X.